Wendall Wierenga - Feb 6, 2023 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role: Director
Signature: /s/ John Faurescu, attorney-in-fact for Dr. Wierenga
Stock symbol: CYTK
Transactions as of: Feb 6, 2023
Transactions value $: -$267,960
Form type: 4
Date filed: 2/8/2023, 03:01 PM
Previous filing: Jan 4, 2023
Next filing: Apr 5, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYTK	Common Stock	Options Exercise	$47K	+7K	+55.85%	$6.72^*	19.5K	Feb 6, 2023	Direct	F1
transaction	CYTK	Common Stock	Sale	-$315K	-7K	-35.84%	$45.00	12.5K	Feb 6, 2023	Direct	F1

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CYTK	Non-Qualified Stock Option (Right to Buy)	Options Exercise	$0	-7K	-53.76%	$0.00	6.02K	Feb 6, 2023	Common Stock	7K	$6.72	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on November 8, 2022.